TickerKhojComparison · NSE · data 2026-11-03
Kilitch Drugs (India) Limited vs Shree Ganesh Remedies Ltd.
In plain words
Size: Shree Ganesh Remedies Ltd. is about 1.1 times the market value of Kilitch Drugs (India) Limited.
Valuation (P/E): Shree Ganesh Remedies Ltd. 49.8 vs Kilitch Drugs (India) Limited 23.5.
Profit growth over 3 years: Kilitch Drugs (India) Limited 42.4% a year vs Shree Ganesh Remedies Ltd. 1.4% a year.
Debt to equity: Kilitch Drugs (India) Limited 0.32 vs Shree Ganesh Remedies Ltd. 0.19.
Differences in the numbers, not a recommendation of either stock.
Side by side
| KILITCH | SGRL | |
|---|---|---|
| Price | ₹205.72 | ₹598.85 |
| Market cap | ₹703 cr | ₹792 cr |
| P/E | 23.5 | 49.8 |
| P/B | — | — |
| ROE | 12.5% | 11.5% |
| ROCE | 12.3% | 14.4% |
| Debt / equity | 0.32 | 0.19 |
| Operating margin | 13.7% | 20.8% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 19.0% | 6.6% |
| Profit growth, 3 years (yearly) | 42.4% | 1.4% |
| 1-year return | 6.2% | 21.0% |
| Revenue, last 12 months | ₹237 cr | ₹99 cr |
| Net profit, last 12 months | ₹30 cr | ₹15 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹3 cr | — |
| Quarter profit vs a year earlier | -4.0% | — |
| Promoter holding | 63.77% | — |
| Health check | Strong (7.2/10) | Average (5.1/10) |
Common questions
Which has a higher P/E, Kilitch Drugs (India) Limited or Shree Ganesh Remedies Ltd.?
Shree Ganesh Remedies Ltd. trades at the higher P/E (49.8 against 23.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Kilitch Drugs (India) Limited (12.5% against 11.5%).
Which carries more debt?
Kilitch Drugs (India) Limited has the higher debt-to-equity ratio (0.32 against 0.19).